Finally, while PP2A inhibition may help cancer therapy in combination with DNA damaging therapeutics by promoting aberrant progression into mitosis, our results cast doubt on the possibility that targeting PP2A activity may help to improve efficacy of widely used anticancer drugs that target the mitotic spindle like taxanes and vinca alkaloids by affecting the SAC-dependent mitotic delay [27, 28]. This evidence concerns the gene PTPA and cancer.